Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Defining the vulnerable patient with myeloma—a frailty position paper of the European Myeloma Network
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-18
DOI
10.1038/s41375-020-0918-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tfh cell subset biomarkers and inflammatory markers are associated with frailty status and frailty subtypes in the community-dwelling older population: a cross-sectional study
- (2020) Ming-Juan Yin et al. Aging-US
- Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities
- (2020) Claudia A. M. Stege et al. LEUKEMIA
- Simplified frailty assessment tools: are we really capturing frailty or something else?
- (2020) Smith Giri et al. LEUKEMIA
- Inflammatory biomarkers of frailty
- (2020) Mirela Vatic et al. EXPERIMENTAL GERONTOLOGY
- Myokines as biomarkers of frailty and cardiovascular disease risk in females
- (2020) Kevin F. Boreskie et al. EXPERIMENTAL GERONTOLOGY
- Biomarkers of frailty: Moving the field forward
- (2020) Anna Picca et al. EXPERIMENTAL GERONTOLOGY
- Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial
- (2020) Sandra Maria Dold et al. HAEMATOLOGICA
- Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
- (2020) Monika Engelhardt et al. HAEMATOLOGICA
- MRI Quantitation of Abdominal Skeletal Muscle Correlates with CT-Based Analysis: Implications for Sarcopenia Measurement
- (2019) Amir Ishaq Khan et al. Applied Physiology Nutrition and Metabolism
- A clinical prediction model for outcome and therapy delivery in transplant-ineligible patients with myeloma (UK Myeloma Research Alliance Risk Profile): a development and validation study
- (2019) Gordon Cook et al. Lancet Haematology
- Frailty in multiple myeloma: the need for harmony to prevent doing harm
- (2019) Sonja Zweegman et al. Lancet Haematology
- Current and emerging biomarkers of frailty in the elderly
- (2019) Ahmed Al Saedi et al. Clinical Interventions in Aging
- Sarcopenia: revised European consensus on definition and diagnosis
- (2019) Alfonso J Cruz-Jentoft et al. AGE AND AGEING
- Geriatric Assessment and Frailty Scores Predict Mortality in Myeloma: Systematic Review and Meta-analysis
- (2019) Ana S. Salazar et al. Clinical Lymphoma Myeloma & Leukemia
- L3 skeletal muscle index (L3SMI) is a surrogate marker of sarcopenia and frailty in non-small cell lung cancer patients
- (2019) D Portal et al. Cancer Management and Research
- Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
- (2019) Maria-Victoria Mateos et al. HAEMATOLOGICA
- Sarcopenia
- (2019) Alfonso J Cruz-Jentoft et al. LANCET
- From discoveries in ageing research to therapeutics for healthy ageing
- (2019) Judith Campisi et al. NATURE
- Sarcopenia Predicts Overall Survival in Patients with Lung, Breast, Prostate, or Myeloma Spine Metastases Undergoing Stereotactic Body Radiation Therapy (SBRT), Independent of Histology
- (2019) Hesham Mostafa Zakaria et al. NEUROSURGERY
- A comparison of three different approaches to defining frailty in older patients with multiple myeloma
- (2019) Ariel Isaacs et al. Journal of Geriatric Oncology
- MRI‐Derived Biomarkers Related to Sarcopenia: A Systematic Review
- (2019) Marina Codari et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults
- (2019) Justin Chew et al. Journal of Nutrition Health & Aging
- A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial
- (2019) Thierry Facon et al. LEUKEMIA
- Validation of a New Clinical Prediction Model for Outcome in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation; A Population-Based Study from the Danish National Multiple Myeloma Registry
- (2019) Louise Redder et al. BLOOD
- The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the Myeloma XI trial
- (2019) Charlotte Pawlyn et al. LEUKEMIA
- Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood
- (2018) Niharika Arora Duggal et al. AGING CELL
- The association between telomere length and frailty: A systematic review and meta-analysis
- (2018) Jianghua Zhou et al. EXPERIMENTAL GERONTOLOGY
- High plasma adiponectin levels are associated with frailty in a general old-old population: The Septuagenarians, Octogenarians, Nonagenarians Investigation with Centenarians study
- (2018) Motonori Nagasawa et al. Geriatrics & Gerontology International
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- Global cancer incidence in older adults, 2012 and 2035: A population-based study
- (2018) Sophie Pilleron et al. INTERNATIONAL JOURNAL OF CANCER
- Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology
- (2018) Supriya G. Mohile et al. JOURNAL OF CLINICAL ONCOLOGY
- Exploring Genetic Outcomes as Frailty Biomarkers
- (2018) Vanessa Valdiglesias et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Strong Relation between Muscle Mass Determined by D3-creatine Dilution, Physical Performance and Incidence of Falls and Mobility Limitations in a Prospective Cohort of Older Men
- (2018) Peggy M Cawthon et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Wearable Sensors and the Assessment of Frailty among Vulnerable Older Adults: An Observational Cohort Study
- (2018) Javad Razjouyan et al. SENSORS
- Prediction of sarcopenia using a combination of multiple serum biomarkers
- (2018) Ju Yeon Kwak et al. Scientific Reports
- Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
- (2018) Johannes M. Waldschmidt et al. HAEMATOLOGICA
- Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?
- (2018) Tamas Fulop et al. Frontiers in Immunology
- Global Burden of Multiple Myeloma
- (2018) Andrew J. Cowan et al. JAMA Oncology
- Quick and Simple FRAIL Scale Predicts Incident Activities of Daily Living (ADL) and Instrumental ADL (IADL) Disabilities: A Systematic Review and Meta-analysis
- (2018) Gotaro Kojima Journal of the American Medical Directors Association
- Geriatric Assessment in Older Adults with Multiple Myeloma
- (2018) Tanya M. Wildes et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Inflammaging 2018: An update and a model
- (2018) Claudio Franceschi et al. SEMINARS IN IMMUNOLOGY
- Age, gender, and percentage of circulating osteoprogenitor (COP) cells: The COP Study
- (2017) Piumali Gunawardene et al. EXPERIMENTAL GERONTOLOGY
- A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
- (2017) Monika Engelhardt et al. HAEMATOLOGICA
- Frailty Index Developed From a Cancer-Specific Geriatric Assessment and the Association With Mortality Among Older Adults With Cancer
- (2017) Emily J. Guerard et al. Journal of the National Comprehensive Cancer Network
- Management of multiple myeloma in older adults: Gaining ground with geriatric assessment
- (2017) Tanya M. Wildes et al. Journal of Geriatric Oncology
- A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
- (2017) Monika Engelhardt et al. HAEMATOLOGICA
- The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study
- (2017) Henrik Gregersen et al. Cancer Medicine
- Biomarkers to identify and isolate senescent cells
- (2016) Mantas Matjusaitis et al. AGEING RESEARCH REVIEWS
- N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
- (2016) Paolo Milani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores
- (2016) M. Engelhardt et al. HAEMATOLOGICA
- Concise review ‐ Treatment of multiple myeloma in the very elderly: How do novel agents fit in?
- (2016) Nicolas Kint et al. Journal of Geriatric Oncology
- Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores
- (2016) M. Engelhardt et al. HAEMATOLOGICA
- New prognostic tools for myeloma
- (2015) U.-H. Mellqvist BLOOD
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century
- (2015) Dianne Pulte et al. BRITISH JOURNAL OF HAEMATOLOGY
- Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
- (2015) M. Delforge et al. HAEMATOLOGICA
- Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
- (2015) Antonio Palumbo et al. JOURNAL OF CLINICAL ONCOLOGY
- Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
- (2015) M. Delforge et al. HAEMATOLOGICA
- Limited value of the international staging system for predicting long-term outcome of transplant-ineligible, newly diagnosed, symptomatic multiple myeloma in the era of novel agents
- (2014) Junya Kuroda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
- (2014) Lotfi Benboubker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of categorization method, regression type, and variable distribution on the inflation of Type-I error rate when categorizing a confounding variable
- (2014) Jean-Louis Barnwell-Ménard et al. STATISTICS IN MEDICINE
- Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials
- (2013) S. Bringhen et al. HAEMATOLOGICA
- Plasma Adiponectin Levels Correlate Positively with an Increasing Number of Components of Frailty in Male Elders
- (2013) Jaw-Shiun Tsai et al. PLoS One
- Assessment of Vulnerability Measures and Their Effect on Survival in a Real-Life Population of Multiple Myeloma Patients Registered at Marche Region Multiple Myeloma Registry
- (2012) Massimo Offidani et al. Clinical Lymphoma Myeloma & Leukemia
- Prevalence of Frailty in Community-Dwelling Older Persons: A Systematic Review
- (2012) Rose M. Collard et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
- (2012) Janet E. McElhaney et al. VACCINE
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
- (2011) A. Palumbo et al. BLOOD
- Prognostic versus predictive value of biomarkers in oncology
- (2008) C.N.A.M. Oldenhuis et al. EUROPEAN JOURNAL OF CANCER
- Telomeres and frailty
- (2008) J. Woo et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
- (2008) Jean-Philippe Coppé et al. PLOS BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search